John L. Knopf, CEO and President at ACCELERON PHARMA INC (XLRN), sold 17,500 shares at $32.58 ($555K) on 2014-07-07, disclosed to the SEC on 2014-07-09.
Scheduled sale ($555k) by CEO and President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.42 | 5,417 | $170K | 30.6% |
| 2 | $31.43 | 7,512 | $236K | 42.5% |
| 3 | $32.58 | 2,083 | $68K | 12.2% |
| 4 | $32.66 | 2,488 | $81K | 14.6% |
| Total | $31.74 avg | 17,500 | $555K | 100% |
| Filing → |
| XLRN | SELL | 2016-05-20 | $3.3M | — | Filing → |
| XLRN | SELL | 2015-10-09 | $463K | — | Filing → |
| XLRN | SELL | 2015-09-10 | $574K | — | Filing → |